ZA824339B - Compositions for treating glaucoma - Google Patents

Compositions for treating glaucoma

Info

Publication number
ZA824339B
ZA824339B ZA824339A ZA824339A ZA824339B ZA 824339 B ZA824339 B ZA 824339B ZA 824339 A ZA824339 A ZA 824339A ZA 824339 A ZA824339 A ZA 824339A ZA 824339 B ZA824339 B ZA 824339B
Authority
ZA
South Africa
Prior art keywords
compositions
treating glaucoma
glaucoma
treating
Prior art date
Application number
ZA824339A
Other languages
English (en)
Inventor
W Matier
Tsam Kam Sheung
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of ZA824339B publication Critical patent/ZA824339B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA824339A 1981-06-23 1982-06-18 Compositions for treating glaucoma ZA824339B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,657 US4402974A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Publications (1)

Publication Number Publication Date
ZA824339B true ZA824339B (en) 1983-04-27

Family

ID=23057572

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA824339A ZA824339B (en) 1981-06-23 1982-06-18 Compositions for treating glaucoma

Country Status (18)

Country Link
US (1) US4402974A (zh)
EP (1) EP0081580B1 (zh)
JP (1) JPS58500997A (zh)
AT (1) AT384017B (zh)
AU (1) AU559541B2 (zh)
CA (1) CA1272733C (zh)
CH (1) CH655497B (zh)
ES (1) ES8401927A1 (zh)
GB (2) GB2112785B (zh)
GR (1) GR76848B (zh)
IL (1) IL66069A0 (zh)
IT (1) IT1156057B (zh)
NL (1) NL8220251A (zh)
NZ (1) NZ200971A (zh)
PH (1) PH18383A (zh)
SE (1) SE464300B (zh)
WO (1) WO1983000043A1 (zh)
ZA (1) ZA824339B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
US4604481A (en) * 1980-11-28 1986-08-05 American Hospital Supply Corporation Compounds for treatment or prophylaxis of cardiac disorders
EP0053893B1 (en) * 1980-12-09 1985-03-20 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
US4579867A (en) * 1984-04-09 1986-04-01 American Hospital Supply Corporation Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4966914A (en) * 1988-12-15 1990-10-30 E. I. Du Pont De Nemours And Company Oculoselective beta-blockers as antiglaucoma agents
US4897417A (en) * 1988-12-15 1990-01-30 E. I. Du Pont De Nemours & Co. Prodrugs of 3,4-hydroxy benzoyloxypropanolamines
CH679856A5 (zh) * 1990-07-04 1992-04-30 Lonza Ag
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5543083A (en) * 1994-07-26 1996-08-06 The Procter & Gamble Company Fatty amine derivatives of butylated hydroxy toluene for the protection of surfaces from physical and chemical degradation
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
US7209743B2 (en) * 2004-04-22 2007-04-24 Telefonaktiebolaget Lm Ericsson (Publ) Base station system and method for compensating traffic channel signal strength measurements in a cellular radio telecommunication network
AU2005247480A1 (en) * 2004-05-25 2005-12-08 Qlt Inc. Oculoselective drugs and prodrugs
US20080300292A1 (en) * 2004-11-08 2008-12-04 Nitromed, Inc Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL75127C (zh) * 1943-10-05
FR1047364A (fr) * 1950-12-28 1953-12-14 Hoechst Ag Esters d'acides alcoylamino-benzoïques, sels d'acides minéraux de ces esters et procédé de préparation de ces corps
NL300886A (zh) * 1962-11-23
US3959351A (en) * 1972-07-24 1976-05-25 Research Corporation Haloalkylbenzoyl esters of di-lower alkylamino alkanols and quaternary lower alkyl salts thereof
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
DE2752659A1 (de) 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
DE2962112D1 (en) * 1978-02-08 1982-03-25 Ici Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
IT8267795A0 (it) 1982-06-22
EP0081580B1 (en) 1987-04-22
GR76848B (zh) 1984-09-04
NL8220251A (nl) 1983-05-02
EP0081580A4 (en) 1983-12-01
AU8737582A (en) 1983-01-18
SE8300912L (sv) 1983-02-18
JPS58500997A (ja) 1983-06-23
GB2112785B (en) 1985-06-05
GB8303060D0 (en) 1983-03-09
GB2145721A (en) 1985-04-03
ES513386A0 (es) 1984-01-01
IL66069A0 (en) 1982-09-30
ES8401927A1 (es) 1984-01-01
GB2112785A (en) 1983-07-27
JPH0428696B2 (zh) 1992-05-15
GB8421939D0 (en) 1984-10-03
ATA903482A (de) 1987-02-15
SE464300B (sv) 1991-04-08
NZ200971A (en) 1985-12-13
CA1272733C (en) 1990-08-14
IT1156057B (it) 1987-01-28
AT384017B (de) 1987-09-25
CH655497B (zh) 1986-04-30
PH18383A (en) 1985-06-19
AU559541B2 (en) 1987-03-12
GB2145721B (en) 1986-02-19
SE8300912D0 (sv) 1983-02-18
WO1983000043A1 (en) 1983-01-06
CA1220716A (en) 1987-04-21
US4402974A (en) 1983-09-06
EP0081580A1 (en) 1983-06-22

Similar Documents

Publication Publication Date Title
GB2111040B (en) Water treating compositions
GB8511539D0 (en) Compositions for treating textiles
ZA824339B (en) Compositions for treating glaucoma
GB2110532B (en) Bendazac compositions for treatment of cataract
JPS57212118A (en) Ophthalmic composition
GB2042338B (en) Compositions for treating glaucoma
DE3262847D1 (en) Heat-polymerisable compositions
ZA824340B (en) Compositions for treating glaucoma
JPS57181011A (en) Nadrol composition for glaucoma treatment
GB2112786B (en) Compositions for treating glaucoma
GB2129841B (en) Backizing compositions for textiles
DE3360742D1 (en) Sterilising compositions
JPS57210098A (en) Composition for treating substrate
GB8411035D0 (en) Formaldehyde-binding compositions
DE3263502D1 (en) Flavour-release compositions
GB2105190B (en) Light-screen compositions
DE3161167D1 (en) Process for the preparation of 1,2-benzisothiazoles
GB2079153B (en) Acetal-acid compositions
DE3171421D1 (en) Anaerobically-curing compositions
GB2110088B (en) Compositions for the treatment of acne
DE3374320D1 (en) Compositions for rust treatment
ZA8032B (en) Compositions for treating glaucoma
JPS57175362A (en) Pasturizing composition
GB2067403B (en) Bezodiazepine compositions
JPS5761651A (en) Under treatment composition